Dechra announces the recent FDA approval of Otiserene® (marbofloxacin, terbinafine, and dexamethasone otic suspension) to treat otitis externa in dogs.  It is the first single-dose, long-acting otitis externa product to leverage the powerful antibiotic marbofloxacin.